Americas: Two COVID-19 vaccines in the United States are awaiting approval

In December, pneumonia in COVID-19 is still raging all over the world, and new confirmed cases in many countries have reached a new high in recent days. According to the latest data, 이상 68 million people have been diagnosed with infection and over 1.55 million people have died in the world. Although “there is still a long way to go” to end the epidemic, as WHO Director-General Tedros Adhanom Ghebreyesus said, the progress of vaccine research and development in COVID-19 makes people begin to see “the light at the end of the tunnel”. In response to the epidemic, Russia and Britain have taken the lead in vaccinating people, some countries have announced the vaccination plan in COVID-19, and some countries are actively ordering vaccines.

현재, there are two COVID-19 vaccines in the United States awaiting the approval of the Food and Drug Administration (FDA), which are the vaccines jointly developed by German Biotechnology Company and Pfizer Pharmaceutical Co., (주), and the vaccines of American Mardner Company. 질병통제예방센터 (질병통제예방센터) predicts that if FDA authorizes the emergency use of these two COVID-19 vaccines in mid-December this year, the supply will reach 40 million doses by the end of this year, which will cover about 20 million people. Experts say that COVID-19 vaccine may not be widely vaccinated in the United States until the spring of 2021. CDC voted on the 1st of this month, suggesting that American state and local governments should give priority to medical workers, long-term residents of nursing homes and nursing staff as the first vaccination targets of COVID-19 vaccine.

The Canadian government announced on the 7th that it will receive the first batch of 249,000 doses of COVID-19 vaccine jointly developed by German Biotechnology Company and Pfizer Pharmaceuticals Co., 주식회사. These vaccines are expected to give priority to the vulnerable groups, which are specifically planned by the provinces themselves. 있다 14 vaccine distribution centers in Canada. Brazilian Health Minister Eduardo Pazoelo said on the 8th that his country signed a letter of intent for cooperation with Pfizer Pharmaceuticals Co., 주식회사. of the United States, ordering more than 70 million doses of vaccines. 같은 날에, after meeting with the governors of various States, Pazionelo stated that the government would open up procurement channels to obtain any effective COVID-19 vaccine approved by the Brazilian National Health Supervision Bureau.

The Mexican Foreign Minister announced to the media on the 8th that the country will receive 250,000 doses of COVID-19 vaccine in December, and will give priority to vaccinating medical workers this month.